Pfizer Splits Into 3 Segments In Latest Shakeup
Pfizer Inc. on Monday said it would shuffle its internal operations to create new business segments focused on brand-name and generic drugs, the latest shakeup for the pharmaceutical giant and a...To view the full article, register now.
Already a subscriber? Click here to view full article